Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies
The association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and breast cancer risk in the Chinese population has been widely reported, but results were inconsistent. In order to derive a more precise estimation of the relationship, a meta-analysis was performed. Eligible a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932174/ https://www.ncbi.nlm.nih.gov/pubmed/24078451 http://dx.doi.org/10.1007/s13277-013-1234-9 |
_version_ | 1782304757623291904 |
---|---|
author | Liang, Hongjie Yan, Yulan Li, Taijie Li, Ruolin Li, Meng Li, Shan Qin, Xue |
author_facet | Liang, Hongjie Yan, Yulan Li, Taijie Li, Ruolin Li, Meng Li, Shan Qin, Xue |
author_sort | Liang, Hongjie |
collection | PubMed |
description | The association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and breast cancer risk in the Chinese population has been widely reported, but results were inconsistent. In order to derive a more precise estimation of the relationship, a meta-analysis was performed. Eligible articles were identified through search of databases including Medline, PubMed, Web of Science, Embase, Chinese Biomedical Literature Database (CBM, Chinese), China National Knowledge Infrastructure (CNKI, Chinese), and Wangfang Database (Chinese). The association between the MTHFR polymorphism and breast cancer risk was conducted using odds ratios (ORs) and 95 % confidence intervals (95 % CIs). Finally, a total of 22 studies with 6,103 cases and 7,913 controls were included in our meta-analysis: 13 studies with 3,273 cases and 4,419 controls for C677T polymorphism and 9 studies with 2,830 cases and 3,494 controls for A1298C polymorphism. With regard to C677T polymorphism, significant association was found with breast cancer risk under three models (T vs. C: OR = 1.12, 95 % CI = 1.02–1.23, P = 0.015; TT vs. CC: OR = 1.35, 95 % CI = 1.10–1.67, P = 0.005; TT vs. CC/CT: OR = 1.37, 95 % CI = 1.11–1.70, P = 0.004). There was no significant association found between A1298C polymorphism and breast cancer risk under all genetic models (C vs. A: OR = 0.96, 95 % CI = 0.89–1.03, P = 0.268; CC vs. AA: OR = 0.98, 95 % CI = 0.77–1.26, P = 0.899; AC vs. AA: OR = 0.95, 95 % CI = 0.88–1.02, P = 0.174; CC vs. AC/AA: OR = 1.00, 95 % CI = 0.78–1.28, P = 0.996, CC/AC vs. AA: OR = 0.96, 95 % CI = 0.89–1.02, P = 0.196). In summary, during this meta-analysis, we found that MTHFR C677T polymorphism was significantly associated with breast cancer risk in the Chinese population. Meanwhile, MTHFR A1298C polymorphism was not associated with breast cancer risk in the Chinese population. |
format | Online Article Text |
id | pubmed-3932174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-39321742014-02-28 Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies Liang, Hongjie Yan, Yulan Li, Taijie Li, Ruolin Li, Meng Li, Shan Qin, Xue Tumour Biol Research Article The association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and breast cancer risk in the Chinese population has been widely reported, but results were inconsistent. In order to derive a more precise estimation of the relationship, a meta-analysis was performed. Eligible articles were identified through search of databases including Medline, PubMed, Web of Science, Embase, Chinese Biomedical Literature Database (CBM, Chinese), China National Knowledge Infrastructure (CNKI, Chinese), and Wangfang Database (Chinese). The association between the MTHFR polymorphism and breast cancer risk was conducted using odds ratios (ORs) and 95 % confidence intervals (95 % CIs). Finally, a total of 22 studies with 6,103 cases and 7,913 controls were included in our meta-analysis: 13 studies with 3,273 cases and 4,419 controls for C677T polymorphism and 9 studies with 2,830 cases and 3,494 controls for A1298C polymorphism. With regard to C677T polymorphism, significant association was found with breast cancer risk under three models (T vs. C: OR = 1.12, 95 % CI = 1.02–1.23, P = 0.015; TT vs. CC: OR = 1.35, 95 % CI = 1.10–1.67, P = 0.005; TT vs. CC/CT: OR = 1.37, 95 % CI = 1.11–1.70, P = 0.004). There was no significant association found between A1298C polymorphism and breast cancer risk under all genetic models (C vs. A: OR = 0.96, 95 % CI = 0.89–1.03, P = 0.268; CC vs. AA: OR = 0.98, 95 % CI = 0.77–1.26, P = 0.899; AC vs. AA: OR = 0.95, 95 % CI = 0.88–1.02, P = 0.174; CC vs. AC/AA: OR = 1.00, 95 % CI = 0.78–1.28, P = 0.996, CC/AC vs. AA: OR = 0.96, 95 % CI = 0.89–1.02, P = 0.196). In summary, during this meta-analysis, we found that MTHFR C677T polymorphism was significantly associated with breast cancer risk in the Chinese population. Meanwhile, MTHFR A1298C polymorphism was not associated with breast cancer risk in the Chinese population. Springer Netherlands 2013-09-27 /pmc/articles/PMC3932174/ /pubmed/24078451 http://dx.doi.org/10.1007/s13277-013-1234-9 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Research Article Liang, Hongjie Yan, Yulan Li, Taijie Li, Ruolin Li, Meng Li, Shan Qin, Xue Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies |
title | Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies |
title_full | Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies |
title_fullStr | Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies |
title_full_unstemmed | Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies |
title_short | Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies |
title_sort | methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in chinese population: a meta-analysis of 22 case–control studies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932174/ https://www.ncbi.nlm.nih.gov/pubmed/24078451 http://dx.doi.org/10.1007/s13277-013-1234-9 |
work_keys_str_mv | AT lianghongjie methylenetetrahydrofolatereductasepolymorphismsandbreastcancerriskinchinesepopulationametaanalysisof22casecontrolstudies AT yanyulan methylenetetrahydrofolatereductasepolymorphismsandbreastcancerriskinchinesepopulationametaanalysisof22casecontrolstudies AT litaijie methylenetetrahydrofolatereductasepolymorphismsandbreastcancerriskinchinesepopulationametaanalysisof22casecontrolstudies AT liruolin methylenetetrahydrofolatereductasepolymorphismsandbreastcancerriskinchinesepopulationametaanalysisof22casecontrolstudies AT limeng methylenetetrahydrofolatereductasepolymorphismsandbreastcancerriskinchinesepopulationametaanalysisof22casecontrolstudies AT lishan methylenetetrahydrofolatereductasepolymorphismsandbreastcancerriskinchinesepopulationametaanalysisof22casecontrolstudies AT qinxue methylenetetrahydrofolatereductasepolymorphismsandbreastcancerriskinchinesepopulationametaanalysisof22casecontrolstudies |